Routine blood biomarkers for protein dysregulation and blood cell changes identify a preclinical continuum of multiple myeloma risk years before clinical onset in a large prospective cohort.
Title resolution pending
1 Pith paper cite this work. Polarity classification is still indexing.
1
Pith paper citing it
fields
stat.AP 1years
2025 1verdicts
CONDITIONAL 1representative citing papers
citing papers explorer
-
Routine Blood Biomarkers Reveal a Preclinical Continuum of Multiple Myeloma Risk
Routine blood biomarkers for protein dysregulation and blood cell changes identify a preclinical continuum of multiple myeloma risk years before clinical onset in a large prospective cohort.